Advances and Challenges for GWAS Analysis in Cardiac Diseases: A Focus on Coronary Artery Disease (CAD)

Area of Science:

• Cardiovascular Research
• Genetics and Genomics
• Pharmacology

Background:

• Genome-wide association studies (GWAS) have significantly advanced the understanding of coronary artery disease (CAD) etiology.
• Current CAD drug development faces challenges, necessitating novel strategies and insights.
• Interpreting the link between disease pathology and genetic risk variants identified by GWAS remains a key area of investigation.

Purpose of the Study:

• To review recent advancements and challenges in utilizing GWAS for CAD research.
• To highlight novel insights into CAD's biological mechanisms derived from GWAS findings.
• To discuss the role of GWAS in identifying new therapeutic targets and advancing precision medicine in cardiovascular research.

Main Methods:

• Review of recent literature on genome-wide association studies (GWAS) in coronary artery disease (CAD).
• Integration of multi-omics data with systems genetics approaches.
• Analysis of GWAS outcomes to understand disease pathology and identify causal variants.

Main Results:

• GWAS have provided significant insights into the genetic underpinnings of CAD.
• Challenges persist in identifying specific causal genes and interpreting variant-pathology relationships.
• Novel therapeutic targets and strategies for CAD have been identified through integrated omics and systems genetics.

Conclusions:

• GWAS are crucial for understanding CAD etiology and overcoming drug development hurdles.
• The integration of multi-omics data and systems genetics enhances the discovery of therapeutic targets.
• GWAS analysis is pivotal for advancing precision medicine in cardiovascular research and patient care.